Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Jerome Rey"'
Autor:
Guillaume Berton, Cécile Vicier, Marie-Anne Hospital, Colombe Saillard, Yosr Hicheri, Valerio Maisano, Ferdinand Villetard, Camille Rouzaud, Evelyne D’incan Corda, Jerome Rey, Bilal Mohty, Aude Charbonnier, Aurelien Proux, Norbert Vey, Anthony Goncalves, Sylvain Garciaz
Publikováno v:
HemaSphere, Vol 7, p e4520163 (2023)
Externí odkaz:
https://doaj.org/article/301143d94eb6467fa8b3cb884f0b6126
Autor:
Jean-Christophe Ianotto, Aurélie Chauveau, Françoise Boyer-Perrard, Emmanuel Gyan, Kamel Laribi, Pascale Cony-Makhoul, Jean-Loup Demory, Benoit de Renzis, Christine Dosquet, Jerome Rey, Lydia Roy, Brigitte Dupriez, Laurent Knoops, Laurence Legros, Mohamed Malou, Pascal Hutin, Dana Ranta, Omar Benbrahim, Valérie Ugo, Eric Lippert, Jean-Jacques Kiladjian
Publikováno v:
Haematologica, Vol 103, Iss 3 (2018)
We have previously described the safety and efficacy of pegylated interferon-α2a therapy in a cohort of 62 patients with myeloproliferative neoplasm-associated myelofibrosis followed in centers affiliated to the French Intergroup of Myeloproliferati
Externí odkaz:
https://doaj.org/article/0d5a03dc33044ea0b063692cf18978a6
Autor:
Anne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, Claire Galseran, Jerome Rey, Gaelle Bouvier Borg, Emmanuel Gautherot, Samuel Granjeaud, Jean-François Hamel-Broza, Clemence Demerle, Norbert Ifrah, Catherine Lacombe, Pascale Cornillet-Lefebvre, Jacques Delaunay, Antoine Toubert, Emilie Gregori, Herve Luche, Marie Malissen, Christine Arnoulet, Jacques A. Nunes, Norbert Vey, Daniel Olive
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Accumulating evidence highlights natural killer (NK) cell parameters as potential prognostic factors in cancer patients, which provides a strong rationale for developing therapeutic strategies aiming at restoring NK cell. However, reaching this point
Externí odkaz:
https://doaj.org/article/5133576a9c344b3ca9296d66a3c47857
Autor:
Xavier Thomas, Lilia Boucinha, Christian Recher, Anne-Sophie Michallet, Sophie Ducastelle-Lepretre, Mauricette Michallet, Stéphanie Nguyen, Clément Rocher, Pierre Peterlin, Etienne Paubelle, Florent Malard, Suzanne Tavitian, Colombe Saillard, Marie-Virginie Larcher, Sarah Bertoli, Evelyne D'incan-Corda, Ollivier Legrand, Patrice Chevallier, Emilie Plantamura, Joël Doré, Anne Vekhoff, Simona Lapusan, Jerome Rey, Lila Gilis, Mohamad Mohty, Cyrielle Gasc, Françoise Isnard
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Nature Communications
Nature Communications, Nature Publishing Group, 2021, 12 (1), pp.3084. ⟨10.1038/s41467-021-23376-6⟩
Nature Communications, 2021, 12 (1), pp.3084. ⟨10.1038/s41467-021-23376-6⟩
Nature Communications
Nature Communications, Nature Publishing Group, 2021, 12 (1), pp.3084. ⟨10.1038/s41467-021-23376-6⟩
Nature Communications, 2021, 12 (1), pp.3084. ⟨10.1038/s41467-021-23376-6⟩
Acute myeloid leukemia (AML) intensive chemotherapy combined with broad-spectrum antibiotics, leads to gut microbiota dysbiosis promoting pathological conditions and an increased incidence of complications. Here we report findings from a phase II sin
Autor:
Yannick LE Bris, Jean Galtier, Dina Naguib, Mathieu Wemeau, Jean Claude Chomel, Laurence Legros, Yan Beauverd, Lise Willems, Guillaume Denis, Françoise Boyer perrard, Damien Luque-Paz, Kamel Laribi, Mélanie Mercier, Pascale Cony-Makhoul, Olivier Herault, Lydia Roy, Pierre Sujobert, Lenaig Le Clech, Sylvie Tondeur, Gaelle Laboure, Jerome Rey, Guillou Sophie, Cedric Pastoret, Pascaline Etancelin, Suzanne Tavitian, Charles Bescond, Francois Girodon, Shanti Amé, Viviane Dubruille, Eric Lippert, Chloe James, Barbara Burroni, Marc Fouassier, Marie C Béné, Jean Christophe Ianotto
Publikováno v:
Blood. 140:9668-9669
Autor:
Ella Willenbacher, Zita Borbényi, Steffen Koschmieder, Robert Kralovics, Mario Cazzola, Uwe Platzbecker, Emanuil Gheorghita, Pencho Georgiev, Heinz Gisslinger, Mathieu Puyade, Malgorzata Calbecka, Jerome Rey, Kurt Krejcy, Jiri Mayer, Krzysztof Warzocha, Emilie Cayssials-Caylus, Veronika Buxhofer-Ausch, János Jakucs, Anna Vallova, Georgi Mihaylov, Hans Carl Hasselbalch, Lydia Roy, Vera Yablokova, Olga Cerna, Aleksander Skotnicki, Richard Greil, Jiri Schwarz, Vera Stoeva, Lylia Sivcheva, Zvenyslava Masliak, Halyna Pylypenko, Antonia Hatalova, Delia Dima, Jose Miguel Torregrosa-Diaz, Elena Volodicheva, Jean-Jacques Kiladjian, S V Klymenko, Carlos Besses Raebel, Polina Kaplan, Irina Sokolova, Horia Bumbea, Miklos Egyed, Nicoleta Berbec, Barbara Grohmann-Izay, Alexander Myasnikov, Petr Dulicek, Tamila Lysa, Dominik Wolf, Andrei Cucuianu, Christoph Klade, Mihaela Lazaroiu, Maria Soroka-Wojtaszko, Tamás Masszi, Ernst Forjan, Liana Gercheva-Kyuchukova, Franz Bauer, Dorota Krochmalczyk, Árpád Illés, Mikulas Hrubisko, Jolanta Starzak-Gwozdz, Viktor Rossiev
Publikováno v:
The Lancet Haematology. 7:e196-e208
Summary Background The PROUD-PV and CONTINUATION-PV trials aimed to compare the novel monopegylated interferon ropeginterferon alfa-2b with hydroxyurea, the standard therapy for patients with polycythaemia vera, over 3 years of treatment. Methods PRO
Autor:
Matteo G. Della Porta, Raynier Devillier, Angela Granata, Claude Lemarie, Boris Calmels, Samia Harbi, Lucas Castagna, Thomas Pagliardini, Colombe Saillard, Sabine Furst, Pierre-Jean Weiller, Catherine Faucher, Djamel Mokart, Faezeh Legrand, Christian Chabannon, Stefania Bramanti, Didier Blaise, Wang Lining, Norbert Vey, Valerio Maisano, Aude Charbonnier, Jerome Rey
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:1803-1809
Haploidentical stem cell transplantation (haplo-SCT) with post-transplant cyclophosphamide (PT-Cy) is an alternative treatment for acute myeloid leukemia (AML) patients who lack HLA-matched donors. Relapse after haplo-SCT remains a major concern, esp
Autor:
Zineb Ghrieb, Stéphane Giraudier, Emmanuelle Verger, Christine Chomienne, Robert Kralovics, Nabih Maslah, Jerome Rey, Barbara Grohmann-Izay, Jean-Jacques Kiladjian, Christoph Klade, Lydia Roy, Bruno Cassinat, Heinz Gisslinger, Juliette Soret-Dulphy
Publikováno v:
Blood Cancer Journal, Vol 8, Iss 10, Pp 1-6 (2018)
Blood Cancer Journal
Blood Cancer Journal
Polycythemia vera is characterized by the acquisition of the JAK2V617F mutation. Recommended treatments include hydroxyurea and interferon-alpha. Several groups have reported a reduction in the JAK2 mutant allele burden in interferon-treated patients
Autor:
Jean-Claude Chomel, Jean-Christophe Ianotto, Laurane Cottin, Pierre Sujobert, Véronique Mansat-De Mas, Barbara Burroni, Vincent Cussac, Nathalie Jézéquel, Brigitte Dupriez, Bruno Cassinat, Emmanuelle Verger, Raouf Ben Abdelali, Dana Ranta, Damien Luque Paz, Olivier Kosmider, Olivier Mansier, Gabriel Etienne, Jerome Rey, Maxime Renard, Jean-Jacques Kiladjian, Fabienne Vacheret, Guillaume Denis, Anne Murati, Jérémie Riou, Pascal Mossuz, Françoise Boyer, Eric Lippert, Yannick Le Bris, Pascale Cony-Makhoul, Ivan Sloma, Anouk Walter-Petrich, Suzanne Tavitian, Stéphane Giraudier, Stéphane Girault, Aurélie Chauveau, Gérard Socié, François Girodon, Lydia Roy, Olivier Nibourel, Borhane Slama, Valérie Ugo, Margot Robles, Mathieu Wemeau
Publikováno v:
Blood Advances
Blood Advances, 2021, 5, pp.1442-1451. ⟨10.1182/bloodadvances.2020003444⟩
Blood Advances, The American Society of Hematology, 2021, 5, pp.1442-1451. ⟨10.1182/bloodadvances.2020003444⟩
Blood Adv
Blood Advances, 2021, 5, pp.1442-1451. ⟨10.1182/bloodadvances.2020003444⟩
Blood Advances, The American Society of Hematology, 2021, 5, pp.1442-1451. ⟨10.1182/bloodadvances.2020003444⟩
Blood Adv
We aimed to study the prognostic impact of the mutational landscape in primary and secondary myelofibrosis. The study included 479 patients with myelofibrosis recruited from 24 French Intergroup of Myeloproliferative Neoplasms (FIM) centers. The mole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c8940c1350fb349d712d80d7c3b70f5
https://www.hal.inserm.fr/inserm-03187575/document
https://www.hal.inserm.fr/inserm-03187575/document
Autor:
Stefan N. Constantinescu, Xénia Cabagnols, Florence Lorre, Philippe Rameau, Caroline Marty, Florence Pasquier, Valérie Ugo, Jerome Rey, Matthieu Mosca, Isabelle Plo, Amandine Tisserand, William Vainchenker, Mira El-Khoury, Fabrizia Favale, Lydia Roy, Christophe Marzac, Hana Raslova, Najet Debili, Gaëlle Vertenoeil, Olivier Bluteau, Eric Solary, Nicole Casadevall, Graciela Rabadan Moraes, Jean-Christophe Ianotto
Publikováno v:
Oncogene, Vol. 39, no. 31, p. 5323-5337 (2020)
Mutations of calreticulin (CALRm) define a subtype of myeloproliferative neoplasms (MPN). We studied the biological and genetic features of CALR-mutated essential thrombocythemia and myelofibrosis patients. In most cases, CALRm were found in granuloc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4394944f20d141ad49d0605ecabce302
https://hdl.handle.net/2078.1/235176
https://hdl.handle.net/2078.1/235176